Literature DB >> 11326861

Studies of primary angle closure glaucoma in China.

W Ningli1, Z Wenbin, Y Tiancai, Y Qiang, L Mingying, L Meihua.   

Abstract

The recent researches on primary angle closure glaucoma (PACG) in China were reviewed. The prevalence of PACG (0.41%) in chinese is between the Caucasian and Eskimos, and chronic type is the dominant type in PACG. However, with the economic development and medical care improvements, the prevalence condition of PACG may change; several researches discovered that the mechanism of PACG, especially the chronic type, is not only because of pupil-blocking but also closely related to the mechanism of crowding of peripheral iris and the anterior location of the ciliary body. We supposed that PACG can be divided into several subtypes based on this mechnism. Also, we believe that the use of ultrasound biomicroscopy (UBM) and ophthalmic laser in China has promoted the research of PACG and improved the level of prevention and treatment of PACG.

Entities:  

Mesh:

Year:  1997        PMID: 11326861

Source DB:  PubMed          Journal:  Yan Ke Xue Bao        ISSN: 1000-4432


  4 in total

1.  Ocular biometry in the adult population in rural central China: a population-based, cross-sectional study.

Authors:  Ting Fu; Yin-Wei Song; Zhi-Qi Chen; Jun-Wen He; Kun Qiao; Xu-Fang Sun; Hong Zhang; Jun-Ming Wang
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

2.  Ocular Biometry and Intra Ocular Lens Power among Cataract Patients in Rural Eastern Ethiopia.

Authors:  Mandefro Sintayehu Kassa; Girum W Gessesse
Journal:  Ethiop J Health Sci       Date:  2021-07

3.  Increased SPARC expression in primary angle closure glaucoma iris.

Authors:  Jocelyn Chua; Li Fong Seet; Yuzhen Jiang; Roseline Su; Hla Myint Htoon; Amanda Charlton; Tin Aung; Tina T Wong
Journal:  Mol Vis       Date:  2008-10-20       Impact factor: 2.367

4.  Pupil Size Associated with the Largest Iris Volume in Normal Chinese Eyes.

Authors:  Shuning Li; Jing Jiang; Yiquan Yang; Gewei Wu; Shi-Ming Li; Ravi Thomas; Ningli Wang
Journal:  J Ophthalmol       Date:  2018-12-27       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.